» Articles » PMID: 23360156

Dry Eye As a Mucosal Autoimmune Disease

Overview
Journal Int Rev Immunol
Publisher Informa Healthcare
Date 2013 Jan 31
PMID 23360156
Citations 146
Authors
Affiliations
Soon will be listed here.
Abstract

Dry eye is a common ocular surface inflammatory disease that significantly affects quality of life. Dysfunction of the lacrimal function unit (LFU) alters tear composition and breaks ocular surface homeostasis, facilitating chronic inflammation and tissue damage. Accordingly, the most effective treatments to date are geared towards reducing inflammation and restoring normal tear film. The pathogenic role of CD4+ T cells is well known, and the field is rapidly realizing the complexity of other innate and adaptive immune factors involved in the development and progression of disease. The data support the hypothesis that dry eye is a localized autoimmune disease originating from an imbalance in the protective immunoregulatory and proinflammatory pathways of the ocular surface.

Citing Articles

Cytokines in age-related eye diseases: pathogenesis and potential targets for innovative therapies.

Zhang T, Liu M Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40021512 DOI: 10.1007/s00210-025-03926-1.


Evaluation of the Performance of an Ocular Surface Modulator Containing ST-Lysyal Versus Hyaluronic Acid Eyedrops in Patients with Dry Eye Disease: A Pilot Study.

Barabino S, Rosa A, Marini S, Bianchi C, Rolando M Ophthalmol Ther. 2024; 14(1):117-128.

PMID: 39560701 PMC: 11724810. DOI: 10.1007/s40123-024-01062-2.


Anti-inflammatory effects of LCB 03-0110 on human corneal epithelial and murine T helper 17 cells.

Truong D, Yang B, Song C Korean J Physiol Pharmacol. 2024; 29(2):205-214.

PMID: 39539175 PMC: 11842296. DOI: 10.4196/kjpp.24.166.


The epithelial barrier theory and its associated diseases.

Sun N, Ogulur I, Mitamura Y, Yazici D, Pat Y, Bu X Allergy. 2024; 79(12):3192-3237.

PMID: 39370939 PMC: 11657050. DOI: 10.1111/all.16318.


Remote-controlled dexamethasone-duration on eye-surface with a micelle-magnetic nanoparticulate co-delivery system for dry eye disease.

Zheng Q, Ge C, Li K, Wang L, Xia X, Liu X Acta Pharm Sin B. 2024; 14(8):3730-3745.

PMID: 39220865 PMC: 11365393. DOI: 10.1016/j.apsb.2024.05.004.


References
1.
Jin Y, Shen L, Chong E, Hamrah P, Zhang Q, Chen L . The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol Vis. 2007; 13:626-34. PMC: 2669510. View

2.
Albertsmeyer A, Kakkassery V, Spurr-Michaud S, Beeks O, Gipson I . Effect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells. Exp Eye Res. 2009; 90(3):444-51. PMC: 2880853. DOI: 10.1016/j.exer.2009.12.009. View

3.
Sathe S, Sakata M, Beaton A, Sack R . Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid. Curr Eye Res. 1998; 17(4):348-62. DOI: 10.1080/02713689808951215. View

4.
Zhang X, Chen W, de Paiva C, Corrales R, Volpe E, McClellan A . Interferon-γ exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Invest Ophthalmol Vis Sci. 2011; 52(9):6279-85. PMC: 3176027. DOI: 10.1167/iovs.10-7081. View

5.
Nava A, Barton K, Monroy D, Pflugfelder S . The effects of age, gender, and fluid dynamics on the concentration of tear film epidermal growth factor. Cornea. 1997; 16(4):430-8. View